在阿尔茨海默氏病的特定领域认知障碍的tau网络映射
Ying Luan1, Anna Rubinski2, Davina Biel2
1Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China; Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig Maximilian University (LMU), Munich, Germany.
NeuroImage. Clinical
|November 7, 2024
概括
阿尔茨海默氏症 (AD) 的tau病理学将大脑网络中断与认知能力下降联系起来. 特定大脑区域的积与记忆,执行功能和语言的障碍相关,揭示了特定领域的效应.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 医疗成像医学成像
背景情况:
- 纤维状病理在阿尔茨海默氏症 (AD) 期间在大脑中逐渐积累.
- 区域性tau负担与特定认知缺陷之间的确切关系,有助于AD多样化的患者表现,仍然不完全理解.
研究的目的:
- 为了研究积在大脑中的位置如何与阿尔茨海默病的明显认知障碍有关.
- 利用功能连接学来映射tau沉积到大脑网络上,并评估其对特定领域认知的影响.
主要方法:
- 区域性陶质子发射断层扫描 (PET) 积累被映射到规范性功能性大脑连接体上.
- 在两个独立的AD患者队列中,tau连接性配置和认知领域 (情节性记忆,执行功能,语言) 之间的关联得到了交叉验证.
- 研究了局部-PET水平对特定域损伤网络和认知表现的影响.
主要成果:
- 鉴定了认知领域特定的损伤网络,其中积与网络的接近预测了该领域的更严重损伤.
- 增加的tau-PET水平与域特定网络内的连接性降低相关.
- 网络连接的减少与相应的认知领域的表现下降有显著的关联.
结论:
- 陶积累与功能性大脑网络的拓接近与阿尔茨海默病中特定领域的认知缺陷有关.
- 由区域沉积驱动的网络连接中断可能是对认知影响的关键机制.
- 功能连接学为理解在阿尔茨海默病异质性中的作用提供了一个框架.
相关概念视频
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165


